Evidence map›Paper›PMID 38888311›Full record

ArticlemBio2024

The SAMHD1-MX2 axis restricts HIV-1 infection at postviral DNA synthesis.

Haoran Guo, Wanying Yang, Huili Li, Jiaxin Yang, Yuehan Huang, Yubin Tang, Shijin Wang, Fushun Ni, Weiming Yang, Xiao-Fang Yu and 1 more

Abstract read
In one paragraph

Article in mBio, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Haoran GuoInstitute of Virology and AIDS Research, First Hospital, Jilin University, Changchun, Jilin, China.
Wanying YangInstitute of Virology and AIDS Research, First Hospital, Jilin University, Changchun, Jilin, China.
Huili LiInstitute of Virology and AIDS Research, First Hospital, Jilin University, Changchun, Jilin, China.ORCID 0009-0007-3135-2358
Jiaxin YangInstitute of Virology and AIDS Research, First Hospital, Jilin University, Changchun, Jilin, China.
Yuehan HuangInstitute of Virology and AIDS Research, First Hospital, Jilin University, Changchun, Jilin, China.
Yubin TangInstitute of Virology and AIDS Research, First Hospital, Jilin University, Changchun, Jilin, China.
Shijin WangInstitute of Virology and AIDS Research, First Hospital, Jilin University, Changchun, Jilin, China.
Fushun NiInstitute of Virology and AIDS Research, First Hospital, Jilin University, Changchun, Jilin, China.
Weiming YangNIH/NIDCR, Bethesda, Maryland, USA.
Xiao-Fang YuCancer Institute (Key Laboratory of Cancer Prevention and Intervention China National Ministry of Education), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.ORCID 0000-0002-6104-3456
Wei WeiInstitute of Virology and AIDS Research, First Hospital, Jilin University, Changchun, Jilin, China.ORCID 0000-0003-4456-840X

Funding

MOST | National Natural Science Foundation of China (NSFC) 32222005, 82372226MOST | National Natural Science Foundation of China (NSFC) 82172246
6 · The paper itself

Abstract

HIV-1 replication is tightly regulated in host cells, and various restriction factors have important roles in inhibiting viral replication. SAMHD1, a well-known restriction factor, suppresses HIV-1 replication by hydrolyzing intracellular dNTPs, thereby limiting the synthesis of viral cDNA in quiescent cells. In this study, we revealed an additional and distinct mechanism of SAMHD1 inhibition during the postviral cDNA synthesis stage. Using immunoprecipitation and mass spectrometry analysis, we demonstrated the interaction between SAMHD1 and MX2/MxB, an interferon-induced antiviral factor that inhibits HIV-1 cDNA nuclear import. The disruption of endogenous MX2 expression significantly weakened the ability of SAMHD1 to inhibit HIV-1. The crucial region within SAMHD1 that binds to MX2 has been identified. Notably, we found that SAMHD1 can act as a sensor that recognizes and binds to the incoming HIV-1 core, subsequently delivering it to the molecular trap formed by MX2, thereby blocking the nuclear entry of the HIV-1 core structure. SAMHD1 mutants unable to recognize the HIV-1 core showed a substantial decrease in antiviral activity. Certain mutations in HIV-1 capsids confer resistance to MX2 inhibition while maintaining susceptibility to suppression by the SAMHD1-MX2 axis. Overall, our study identifies an intriguing antiviral pattern wherein two distinct restriction factors, SAMHD1 and MX2, collaborate to establish an alternative mechanism deviating from their actions. These findings provide valuable insight into the complex immune defense networks against exogenous viral infections and have implications for the development of targeted anti-HIV therapeutics. IMPORTANCE: In contrast to most restriction factors that directly bind to viral components to exert their antiviral effects, SAMHD1, the only known deoxynucleotide triphosphate (dNTP) hydrolase in eukaryotes, indirectly inhibits viral replication in quiescent cells by reducing the pool of dNTP substrates available for viral cDNA synthesis. Our study provides a novel perspective on the antiviral functions of SAMHD1. In addition to its role in dNTP hydrolysis, SAMHD1 cooperates with MX2 to inhibit HIV-1 nuclear import. In this process, SAMHD1 acts as a sensor for incoming HIV-1 cores, detecting and binding to them, before subsequently delivering the complex to the molecular trap formed by MX2, thereby immobilizing the virus. This study not only reveals a new antiviral pathway for SAMHD1 but also identifies a unique collaboration and interaction between two distinct restriction factors, establishing a novel line of defense against HIV-1 infection, which challenges the traditional view of restriction factors acting independently. Overall, our findings further indicate the intricate complexity of the host immune defense network and provide potential targets for promoting host antiviral immune defense.

Indexed as

HIV-1HIV InfectionsMyxovirus Resistance ProteinsSAM Domain and HD Domain-Containing Protein 1Virus ReplicationDNA, ViralHEK293 CellsHost-Pathogen InteractionsHumansProtein BindingDNA, ViralMX2 protein, humanMyxovirus Resistance ProteinsSAM Domain and HD Domain-Containing Protein 1SAMHD1 protein, humanantiviral immune defenseHIVinterferonsMX2/MxBSAMHD1

Identifiers

PMID38888311
PMCPMC11253599

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.